Acknowledgements
We thank the CSIR (New Delhi) for financial assistance and the
University of Kalyani for laboratory facilities.
References
‡ The IUPAC name for propargyl is prop-2-ynyl.
Scheme 3
1 (a) R. Bentley and P. M. Zwitkowits, J. Am. Chem. Soc., 1967, 89,
676; (b) R. Bentley and P. M. Zwitkowits, J. Am. Chem. Soc., 1967,
89, 681.
2 (a) S. Omura, H. Ohno, T. Saheki, Y. Masakazu and A. Nakagawa,
Biochem. Biophys. Res. Commun., 1978, 83, 704; (b) H. Ohno,
T. Saheki, J. Awaya, A. Nakagawa and S. Omura, J. Antibiot., 1978,
31, 1116.
3 (a) W. C. Groutas, W. R. Abrams, R. T. Carrol, M. K. Moi,
K. E. Miller and M. T. Margolis, Experientia, 1984, 40, 361;
(b) W. C. Groutas, M. A. Stanga, M. J. Brubaker, T. L. Huang,
M. K. Moi and R. T. Carrol, J. Med. Chem., 1985, 28, 1106;
(c) R. W. Spencer, L. J. Copp and J. R. Pfister, J. Med. Chem., 1985,
28, 1828; (d ) L. Cook, B. Ternai and P. Ghosh, J. Med. Chem., 1987,
30, 1017.
4 (a) K. Rehse, W. Schinkel and U. Siemann, Arch. Pharm., 1980,
313, 344; (b) K. Rehse and W. Schinkel, Arch. Pharm., 1983,
316, 845; (c) K. Rehse and W. Schinkel, Arch. Pharm., 1983,
316, 988; (d ) K. Rehse and F. Brandt, Arch. Pharm., 1983, 316,
1030.
5 (a) K. C. Majumdar, U. Das and N. K. Jana, J. Org. Chem., 1998, 63,
3550; (b) K. C. Majumdar and T. Bhattacharyya, Tetrahedron Lett.,
2001, 42, 4231.
6 (a) K. C. Majumdar and P. Biswas, Tetrahedron, 1998, 54, 11603;
(b) K. C. Majumdar and P. Biswas, Tetrahedron, 1999, 55, 1449;
(c) K. C. Majumdar and S. K. Samanta, Tetrahedron, 2001, 57,
4955; (d ) K. C. Majumdar and U. Das, J. Org. Chem., 1998, 63,
9997.
7 K. C. Majumdar, S. Ghosh and A. K. Kundu, Synth. Commun.,
2002, 32, 753.
8 K. C. Majumdar and S. Ghosh, Tetrahedron, 2001, 57, 1589.
9 A. M. Bittencourt, O. R. Gottlieb, W. B. Mors, M. Taveira Magal-
haes, S. Mageswaran, W. D. Ollis and I. O. Sutherland, Tetrahedron,
1971, 27, 1043.
10 K. C. Majumdar, A. T. Khan and R. N. De, Synth. Commun., 1988,
18, 1589.
11 (a) J. Zsindely and H. Schmidt, Helv. Chim. Acta, 1968, 51, 1510;
(b) K. C. Majumdar, B. S. Thyagarajan and K. K. Balasubramanian,
J. Heterocycl. Chem., 1973, 10, 159; (c) L. Claisen, Ber., 1912, 45,
3157.
12 H. Kwart and T. J. George, J. Chem. Soc., Chem Commun., 1970,
433.
Scheme 4
intermediate 12. Intermediate 12 may tautomerize to 13 which,
on ‘5-exo’ ring closure, should give compound 11.
Substrates 5a,b,c underwent [3,3] sigmatropic rearrange-
ment at the vinyl propargyl sulfide segment instead of the aryl
propargyl ether moiety. A lesser energy requirement for the
sigmatropic rearrangement in vinyl propargyl systems10 com-
pared to that in aryl propargyl moieties11 may be responsible
for this regioselectivity. Thiopyranopyrone derivatives 6a,b,c
were exclusively obtained in all cases. Thio-Claisen rearrange-
ment of aryl propargyl sulfide is known to give a mixture of two
products viz. 2H-thiochromene and 2-methylthianaphthalene.12
Thio-Claisen rearrangement of heterocyclic substrates is also
known to be accompanied by a [1,3] radical shift.13 However in
the present instance none of the examples gave a mixture of
products which is again a general phenomenon shown by earlier
workers.14
In conclusion, we have successfully exploited thermal sigma-
tropic rearrangements as an expedient avenue towards the
synthesis of fused furanothiopyran heterocyclic ring systems.
This type of ring system is otherwise difficult to construct. The
synthetic approach adopted here may be considered as a mild
and facile pathway for the synthesis of fused furanothiopyran
heterocyclic systems.
13 K. C. Majumdar, N. K. Jana, A. Bandyopadhya and S. K. Ghosh,
Synth. Commun., 2001, 31, 93.
14 (a) L. Brandsma and H. J. Y. Bos, Rec. Trav. Chim. Pays-Bas, 1969,
88, 732; (b) L. Brandsma and Schuiji Largos, Rec. Trav. Chim.
Pays-Bas, 1970, 89, 110.
2140
J. Chem. Soc., Perkin Trans. 1, 2002, 2139–2140